In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your McGill email for more information.
...
ALERTE McGILL! En raison de la pluie verglaçante, tous les cours et activités en présentiel prévus pour le mercredi 11 mars sont annulés. Nous demandons au personnel de ne pas se présenter sur le campus demain, à moins que leur superviseur ne leur demande d’être sur place pour accomplir des fonctions ou activités nécessaires au fonctionnement du campus. Pour plus d’informations, veuillez consulter vos courriels de McGill.

Thomas Durcan

Academic title(s): 

Associate Professor

Thomas Durcan
Branch: 
Université McGill
Department: 
Neurologie et neurochirurgie
Areas of expertise: 
  • IPSCs,
  • neurons,
  • glial cells,
  • translation,
  • partnerships
Biography: 

Dr. Thomas M. Durcan is an Associate Professor within the Montreal Neurological Institute (The Neuro) and McGill University and Director of the Neuro’s Early Drug Discovery Unit (EDDU), focused on the use of human induced pluripotent stem cells (iPSCs) for fundamental and translational discovery project through partnerships with academia and industry. Founded under a decade ago, the group has established a cohort of 200+ iPSCs that have been advanced into both discovery and translational projects and used to generate a wide range of neuronal and glial subtypes, in addition to more advanced 3D brain organoid models, with a focus on Parkinson’s disease, ALS and rare diseases. Working with others, through these models advancements in RNA and precision therapies are advancing within the EDDU.

Back to top